Literature DB >> 12031784

Association of spinothalamic lamina I neurons and their ascending axons with calbindin-immunoreactivity in monkey and human.

A D Craig1, E T Zhang, A Blomqvist.   

Abstract

The calbindin-immunoreactivity of spinothalamic (STT) lamina I neurons and their ascending axons was examined in two experiments. In the first experiment, lamina I STT neurons in macaque monkeys were double-labeled for calbindin and for retrogradely transported WGA*HRP following large (n=2) or small (n=1) injections that included the posterior thalamus. Most, but not all (78%) of the contralateral retrogradely labeled lamina I STT cells were positive for calbindin. Calbindin-immunoreactivity was not selectively associated with any particular anatomical type of lamina I STT cell; 82% of the fusiform cells, 78% of the pyramidal cells and 67% of the multipolar cells were double-labeled. In the second experiment, oblique transverse sections from upper cervical spinal segments of three macaque monkeys, one squirrel monkey and five humans were stained for calbindin-immunoreactivity. In each case, a distinct bundle of fibers was densely stained in the middle of the lateral funiculus. This matches the location of anterogradely labeled ascending lamina I axons observed in prior work in cats and monkeys, and it matches the location of the classically described 'lateral spinothalamic tract' in humans. This bundle had variable shape across cases, an observation that might have clinical significance. These findings support the view that lamina I STT neurons are involved in spinal cordotomies that reduce pain, temperature and itch sensations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031784     DOI: 10.1016/s0304-3959(02)00009-x

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  9 in total

Review 1.  Modulation of sodium channels as pharmacological tool for pain therapy-highlights and gaps.

Authors:  Nilufar Foadi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-23       Impact factor: 3.000

2.  Somatotopy and Organization of Spinothalamic Tracts in the Human Cervical Spinal Cord.

Authors:  Aditya Vedantam; Eduardo Bruera; Kenneth R Hess; Patrick M Dougherty; Ashwin Viswanathan
Journal:  Neurosurgery       Date:  2019-06-01       Impact factor: 4.654

3.  Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.

Authors:  Darin T Okuda; Kara Melmed; Takashi Matsuwaki; Anders Blomqvist; Arthur D Bud Craig
Journal:  Ann Clin Transl Neurol       Date:  2014-07-28       Impact factor: 4.511

4.  Distribution of 28 kDa Calbindin-Immunopositive Neurons in the Cat Spinal Cord.

Authors:  Natalia Merkulyeva; Aleksandr Veshchitskii; Felix Makarov; Yury Gerasimenko; Pavel Musienko
Journal:  Front Neuroanat       Date:  2016-01-28       Impact factor: 3.856

Review 5.  Targeting spinal neuropeptide Y1 receptor-expressing interneurons to alleviate chronic pain and itch.

Authors:  Tyler S Nelson; Bradley K Taylor
Journal:  Prog Neurobiol       Date:  2020-08-07       Impact factor: 11.685

Review 6.  Deep Brain Stimulation of the Posterior Insula in Chronic Pain: A Theoretical Framework.

Authors:  David Bergeron; Sami Obaid; Marie-Pierre Fournier-Gosselin; Alain Bouthillier; Dang Khoa Nguyen
Journal:  Brain Sci       Date:  2021-05-15

7.  A Comparative Study of Three Interneuron Types in the Rat Spinal Cord.

Authors:  Si Chen; Guangqi Yang; Yaxi Zhu; Zongwei Liu; Weiping Wang; Jiayou Wei; Keyi Li; Jiajia Wu; Zhi Chen; Youlan Li; Shuhua Mu; Lisi OuYang; Wanlong Lei
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

8.  Chronic MPTP in Mice Damage-specific Neuronal Phenotypes within Dorsal Laminae of the Spinal Cord.

Authors:  Francesca Biagioni; Giorgio Vivacqua; Gloria Lazzeri; Rosangela Ferese; Simone Iannacone; Paolo Onori; Sergio Morini; Loredana D'Este; Francesco Fornai
Journal:  Neurotox Res       Date:  2020-11-18       Impact factor: 3.911

Review 9.  Pain and the Triple Network Model.

Authors:  Dirk De Ridder; Sven Vanneste; Mark Smith; Divya Adhia
Journal:  Front Neurol       Date:  2022-03-07       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.